Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive
Rigas G Kalaitzidis1, Thalia Panagiotopoulou2, Dimitrios Stagikas2
1Hypertension Excellence Centre, Division of Nephrology, University Hospital of Ioannina, Ioannina, Greece.
Insights
Improving blood pressure control in hypertension involves addressing patient adherence. Stable antihypertensive drug combinations enhance adherence, which is crucial for managing arterial stiffness and cognitive function.
Area of Science:
- Cardiovascular Medicine
- Neuroscience
- Pharmacology
Background:
- Hypertension (HTN) and its cardiovascular (CV) complications are globally increasing, with unsatisfactory blood pressure (BP) control rates.
- Medical inertia and poor treatment adherence significantly contribute to low BP control rates.
- Arterial stiffness, induced by HTN, elevates CV and stroke risk and is linked to cognitive dysfunction.
Purpose of the Study:
- To review the interrelationships between arterial stiffness, cognitive function, and medication adherence in patients with hypertension.
- To explore how arterial stiffness impacts cognitive function and, consequently, treatment adherence.
- To highlight the benefits of addressing arterial stiffness for cognitive health and adherence.
Main Methods:
- Literature review focusing on studies examining hypertension, arterial stiffness, cognitive function, and medication adherence.
- Analysis of the mechanisms linking HTN, arterial stiffness, and cognitive impairment.
- Evaluation of the impact of adherence on BP control and arterial stiffness.
Main Results:
- Hypertension can induce arterial stiffness, which is associated with increased CV and stroke risk.
- HTN-induced arterial stiffness can lead to brain microcirculation disorders and cognitive dysfunction, particularly memory deficits.
- Cognitive dysfunction negatively impacts adherence to antihypertensive drug treatment.
- Compliance with antihypertensive therapy improves BP control and arterial stiffness indices.
Conclusions:
- Stable combinations of antihypertensive drugs improve patient adherence compared to complex regimens.
- Early intervention for arterial stiffness is recommended to enhance cognitive function and improve medication adherence.
- Addressing arterial stiffness is a key strategy for improving overall management of hypertension and its complications.
Abstract:
The incidence of hypertension (HTN) and its cardiovascular (CV) complications are increasing throughout the world. Blood pressure (BP) control remains unsatisfactory worldwide. Medical inertia and poor adherence to treatment are among the factors that can partially explain, why BP control rate remains low. The introduction of a method for measuring the degree of adherence to a given medication is now a prerequisite. Complex treatment regimes, inadequate tolerance and frequent replacements of pharmaceutical formulations are the most common causes of poor adherence. In contrast, the use of stable combinations of antihypertensive drugs leads to improved patient adherence. We aim to review the relationships between arterial stiffness, cognitive function and adherence to medication in patients with HTN. Large artery stiffening can lead to HTN. In turn, arterial stiffness induced by HTN is associated with an increased CV and stroke risk. In addition, HTN can induce disorders of brain microcirculation resulting in cognitive dysfunction. Interestingly, memory cognitive dysfunction leads to a reduced adherence to drug treatment. Compliance with antihypertensive treatment improves BP control and arterial stiffness indices. Early treatment of arterial stiffness is strongly recommended for enhanced cognitive function and increased adherence.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Cognitive Dissonance

